Related Experiment Video

Updated: Apr 19, 2026

Following in Real Time the Impact of Pneumococcal Virulence Factors in an Acute Mouse Pneumonia Model Using Bioluminescent Bacteria
11:32

Following in Real Time the Impact of Pneumococcal Virulence Factors in an Acute Mouse Pneumonia Model Using Bioluminescent Bacteria

Published on: February 23, 2014

15.8K

[Community acquired pneumonia in children: Outpatient treatment and prevention]

D Moreno-Pérez1, A Andrés Martín2, A Tagarro García3

  • 1Infectología Pediátrica e Inmunodeficiencias, Unidad de Gestión Clínica de Pediatría, Hospital Materno-Infantil, Hospital Regional Universitario de Málaga, Grupo de Investigación IBIMA, Departamento de Pediatría y Farmacología, Facultad de Medicina, Universidad de Málaga, Málaga, España.

Anales De Pediatria (Barcelona, Spain : 2003)
|December 10, 2014
PubMed

Insights

Updated guidelines address changing community-acquired pneumonia (CAP) in children, including epidemiology, clinical presentation, and antibiotic resistance. This consensus offers therapeutic approaches and prevention strategies for pediatricians.

Area of Science:

  • Pediatrics
  • Infectious Diseases
  • Pulmonology

Background:

  • Community-acquired pneumonia (CAP) in children has seen significant epidemiological and clinical shifts.
  • Antibiotic resistance patterns are evolving, necessitating updated treatment considerations.
  • Existing guidelines require revision to reflect current challenges in pediatric CAP management.

Purpose of the Study:

  • To establish a consensus on the therapeutic approach for pediatric CAP.
  • To provide updated guidelines for pediatricians managing CAP in children.
  • To address both common and complicated CAP cases, including prevention strategies.

Main Methods:

  • Consensus development by leading Spanish pediatric societies (Infectious Diseases and Chest Diseases).
  • Involvement of the Advisory Committee on Vaccines (CAV-AEP) for prevention aspects.
  • Review of current epidemiology, clinical presentations, and antibiotic resistance data.

Main Results:

  • The document outlines an approach for ambulatory, previously healthy children with CAP.
  • Prevention strategies utilizing currently available vaccines are reviewed.
  • Special situations and complicated forms of pediatric CAP are addressed in a subsequent section.

Conclusions:

  • Updated guidelines are crucial for effective pediatric CAP management.
  • A comprehensive approach considering epidemiology, resistance, and prevention is recommended.
  • Consensus-based recommendations aim to standardize and improve care for children with CAP.

Keywords:
ChildrenCommunity acquired pneumoniaNeumonía adquirida en la comunidadNiñosPrevenciónPreventionResistancesResistenciasStreptococcus pneumoniaeTratamientoTreatmentVaccinesVacunas

More Related Videos

Osteopathic Manipulative Treatment as a Useful Adjunctive Tool for Pneumonia13:27

Osteopathic Manipulative Treatment as a Useful Adjunctive Tool for Pneumonia

Published on: May 6, 2014

49.4K

Related Concept Videos

Pneumonia V: Nursing management and Prevention01:30

Pneumonia V: Nursing management and Prevention

Nursing management of pneumonia involves promoting airway patency, facilitating rest and conserving energy, encouraging fluid intake, maintaining nutrition, and educating patients.
The nurse must practice strict medical asepsis and adhere to infection control guidelines to minimize healthcare-associated infections.
Enhance airway patency
Position the patient correctly to facilitate drainage of the affected lung segments. Manual or mechanical percussion and vibration can also be employed....
4.1K
Pneumonia I: Introduction01:30

Pneumonia I: Introduction

Pneumonia is an acute respiratory infection that targets the lungs, specifically the alveoli. These tiny air sacs, essential for oxygen exchange, become engorged with pus and fluid, severely hindering breathing, decreasing oxygen absorption, and causing significant pain and discomfort during respiration.
Risk Factors
Various factors influence the likelihood of developing pneumonia. Age plays a crucial role, with infants, children under two, and individuals over 65 at increased risk due to their...
1.4K
Pneumonia I: Introduction01:29

Pneumonia I: Introduction

Pneumonia is an infection of the lower respiratory tract that leads to inflammation of the lung parenchyma, often resulting in the accumulation of inflammatory exudate in the alveoli and airways. Unlike the watery, low-protein fluid exudate in pulmonary edema, the exudate in this case is a thick fluid rich in immune cells, proteins, and debris produced during infection and inflammation.This impairs gas exchange and can lead to consolidation of lung tissue. The infection may be caused by a...
16
Pneumonia IV: Management01:28

Pneumonia IV: Management

The treatment of pneumonia varies based on its severity and the causative pathogen. Here is a structured approach to managing pneumonia, integrating pharmaceutical and supportive care strategies.
Bacterial Pneumonia Treatment
For bacterial pneumonia, antibiotics serve as the cornerstone of therapy. Initial treatment often begins with empirical antibiotics, tailored to the anticipated causative organism and adjusted based on culture results. Key antibiotic choices include:
1.1K
Atypical Pneumonia01:14

Atypical Pneumonia

Atypical pneumonia, often caused by Mycoplasma pneumoniae, is a form of pulmonary infection that differs from the classical presentation of bacterial pneumonia in both its cause and clinical symptoms. Mycoplasma pneumoniae is a pleomorphic bacterium notable for its lack of a rigid cell wall. This structural characteristic imparts resistance to beta-lactam antibiotics and significantly influences the bacterium’s behavior within the human host.Other pathogens responsible for the disease...
67
Pneumonia III: Complications and Assessment01:30

Pneumonia III: Complications and Assessment

Pneumonia poses the potential for numerous complications that warrant consideration. These complications include the following:
1.3K